Provided by Tiger Trade Technology Pte. Ltd.

Sunshine Biopharma Inc.

1.06
-0.0200-1.85%
Post-market: 1.05-0.0100-0.94%19:59 EDT
Volume:99.92K
Turnover:107.20K
Market Cap:4.11M
PE:-0.11
High:1.11
Open:1.10
Low:1.05
Close:1.08
52wk High:24.30
52wk Low:1.01
Shares:3.88M
Float Shares:3.81M
Volume Ratio:0.69
T/O Rate:2.62%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-10.0329
EPS(LYR):-14.3739
ROE:-21.92%
ROA:-9.91%
PB:0.15
PE(LYR):-0.07

Loading ...

Sunshine Biopharma shareholders OK Nasdaq-related approval provisions for Series C warrants from $6 million offering

Reuters
·
Jun 09

Sunshine Biopharma wins Canadian approval for generic Xarelto drug rivaroxaban tablets

Reuters
·
Jun 01

NASDAQ TRADE HALT REASON NOT AVAILABLE AT 03:58 AM

Reuters
·
Jun 01

NASDAQ TRADE HALT HALT NEWS PENDING AT 03:28 AM

Reuters
·
May 30

Sunshine Biopharma Inc trading halted, news pending

TIPRANKS
·
May 30

Sunshine Biopharma shareholder approved discounted share issuance above 20% Nasdaq limit

Reuters
·
May 30

Sunshine Biopharma files draft information statement on warrant approval provisions

Reuters
·
May 30

Sunshine Biopharma wins US patent for coronavirus treatment technology

Reuters
·
May 29

Sunshine Biopharma executes 1-for-10 reverse stock split effective June 1 to maintain Nasdaq listing

Reuters
·
May 28

Sunshine Biopharma wins Canadian approval for generic amoxicillin

Reuters
·
May 21

Sunshine Biopharma prices USD 6 million public offering at USD 0.5 per unit

Reuters
·
May 19

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:31 AM

Reuters
·
May 18

Sunshine Biopharma Q1 FY26 net loss widens to $1.24 million; sales fall 9.1% to $8.09 million

Reuters
·
May 14

Sunshine Biopharma files to sell 5.825M common units

TIPRANKS
·
May 13

Sunshine Biopharma expects to reduce expenses by $2M-$3M in 2026

TIPRANKS
·
Apr 06

Sunshine Biopharma FY25 net loss widens 16.39% to $5.98 million

Reuters
·
Apr 03

Sunshine Biopharma delays annual report filing, expects to submit within 15 days

Reuters
·
Apr 01

Sunshine Biopharma Inc expected to post a loss of 27 cents a share - Earnings Preview

Reuters
·
Mar 28